Camber Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,500,000
| Closed | -$76.4M | – | 30 |
|
2025
Q1 | $76.4M | Sell |
1,500,000
-1,700,000
| -53% | -$86.6M | 2.72% | 6 |
|
2024
Q4 | $144M | Sell |
3,200,000
-300,000
| -9% | -$13.5M | 3.34% | 5 |
|
2024
Q3 | $130M | Hold |
3,500,000
| – | – | 4.12% | 6 |
|
2024
Q2 | $107M | Sell |
3,500,000
-500,000
| -13% | -$15.3M | 2.96% | 10 |
|
2024
Q1 | $116M | Hold |
4,000,000
| – | – | 2.85% | 11 |
|
2023
Q4 | $110M | Buy |
4,000,000
+600,000
| +18% | +$16.5M | 2.81% | 10 |
|
2023
Q3 | $76.2M | Buy |
3,400,000
+900,000
| +36% | +$20.2M | 2.51% | 16 |
|
2023
Q2 | $102M | Hold |
2,500,000
| – | – | 3.31% | 12 |
|
2023
Q1 | $121M | Sell |
2,500,000
-250,000
| -9% | -$12.1M | 3.72% | 11 |
|
2022
Q4 | $105M | Buy |
2,750,000
+300,000
| +12% | +$11.5M | 3.6% | 10 |
|
2022
Q3 | $123M | Hold |
2,450,000
| – | – | 3.77% | 8 |
|
2022
Q2 | $98.1M | Buy |
2,450,000
+700,000
| +40% | +$28M | 4.26% | 9 |
|
2022
Q1 | $65.3M | Buy |
1,750,000
+1,000,000
| +133% | +$37.3M | 2.36% | 17 |
|
2021
Q4 | $29.9M | Hold |
750,000
| – | – | 1.03% | 25 |
|
2021
Q3 | $27.9M | Buy |
+750,000
| New | +$27.9M | 0.86% | 26 |
|
2017
Q3 | – | Sell |
-500,000
| Closed | -$9.17M | – | 24 |
|
2017
Q2 | $9.17M | Sell |
500,000
-750,000
| -60% | -$13.7M | 0.45% | 27 |
|
2017
Q1 | $12.3M | Buy |
+1,250,000
| New | +$12.3M | 0.5% | 25 |
|
2016
Q4 | – | Sell |
-2,000,000
| Closed | -$28M | – | 38 |
|
2016
Q3 | $28M | Buy |
2,000,000
+500,000
| +33% | +$7.01M | 1.23% | 21 |
|
2016
Q2 | $10.5M | Buy |
1,500,000
+606,100
| +68% | +$4.25M | 0.51% | 33 |
|
2016
Q1 | $5.76M | Buy |
893,900
+393,900
| +79% | +$2.54M | 0.34% | 38 |
|
2015
Q4 | $16.2M | Buy |
+500,000
| New | +$16.2M | 1.05% | 24 |
|
2015
Q1 | – | Sell |
-525,000
| Closed | -$27.2M | – | 40 |
|
2014
Q4 | $27.2M | Buy |
525,000
+366,851
| +232% | +$19M | 1.81% | 21 |
|
2014
Q3 | $6.96M | Buy |
+158,149
| New | +$6.96M | 0.65% | 29 |
|